COMMUNIQUÉS West-GlobeNewswire

Best Steroid for Women for Muscle Growth and Fat Loss 2025 - Top Anabolic Steroids for Female Bodybuilders With Before and After Results - CrazyBulk
29/04/2025
New York City, April 29, 2025 (GLOBE NEWSWIRE) -- Best steroids for women for building muscle and losing fat presented by CrazyBulk Are you a female bodybuilder or athlete looking to take your physique to the next level [...]
Tevogen Informs Public Shareholders About DRS Accounts And Differences to Brokerage Accounts
29/04/2025
WARREN, N.J., April 29, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), today informed shareholders about several differences between holding shares in Direct Registration [...]
NADP Advocates for Greater Access to Care through Dental Coverage
29/04/2025
Association Represents Dental Benefits Industry at Advocacy in Action DALLAS, April 29, 2025 (GLOBE NEWSWIRE) -- The National Association of Dental Plans (NADP) demonstrated its strong commitment to expanding access to [...]
Louw Alberts Psychology Practice Rebrands from Talk It Out to Strengthen Identity
29/04/2025
Embracing a New Identity: Louw Alberts Psychology Practice Centurion, Gauteng, April 29, 2025 (GLOBE NEWSWIRE) -- Louw Alberts Psychology Practice, a renowned counselling practice based in Centurion, South Africa, has [...]
PLANT ADVANCED TECHONOLIGES (PAT) : Résultats Annuels 2024
29/04/2025
Vandœuvre-lès-Nancy, le 29 avril 2025 – 18 : 00 (CET) Communiqué de presse Pour diffusion immédiate Résultats Annuels 2024 de la Société PAT Premier résultat d'exploitation positif depuis la création de PAT en 2005 : [...]
EssilorLuxottica: Disclosure of transactions in own shares
29/04/2025
Disclosure of transactions in own shares Paris, France (April 29, 2025 - 6:00 pm) – In accordance with the authorization granted by the Annual Shareholders’ Meeting on April 30, 2024, EssilorLuxottica declares that from [...]
EssilorLuxottica: Déclaration de transactions sur actions propres
29/04/2025
Déclaration de transactions sur actions propres Paris, France (29 avril 2025, 18h00) – Conformément à l’autorisation octroyée par l’Assemblée Générale du 30 avril 2024, EssilorLuxottica déclare que du 22 avril 2025 au [...]
Lirum Therapeutics’ LX-101 New Positive Data Selected for Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting
29/04/2025
New York, NY, April 29, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today that new [...]
Combined General Meeting of May 21, 2025 - Availability of preparatory documents
29/04/2025
Press Release Paris – April 29, 2025 – EUROAPI’s shareholders are invited to attend the Combined General Meeting to be held on Wednesday May 21, 2025 at 10:30 a.m. (CET) at 15 bis, rue Traversière 75012 Paris. The [...]
Assemblée Générale mixte du 21 mai 2025 - Modalités de mise à disposition ou de consultation des documents préparatoires
29/04/2025
Communiqué de presse Paris – Le 29 avril 2025 – Les actionnaires d’EUROAPI sont invités à participer à l’Assemblée Générale mixte qui se tiendra le mercredi 21 mai 2025 à 10h30 au 15 bis rue Traversière 75012 Paris. L’ [...]
remMD Launches Glow Guide: A Smart Mobility Accessory Designed to Support Safer, Smarter Movement for Aging Adults
29/04/2025
remMD reveals Glow Guide, a smart mobility accessory combining location services and lighting to assist loved ones with memory loss and fall prevention at night New York, New York, April 29, 2025 (GLOBE NEWSWIRE) -- [...]
Sandoz enters global collaboration license agreement with Henlius to commercialize leading oncology therapy, ipilimumab, in multiple indications
29/04/2025
MEDIA RELEASE Agreement offers rights to commercialize proposed biosimilar of Yervoy®* for treatment of variety of cancer types, targeting net reference medicine sales of USD 2.5 billion[1] Henlius to develop and [...]
Invitation to the presentation of ALK’s first quarter 2025 results on Tuesday, 6 May 2025
29/04/2025
ALK (ALKB.DC / OMX: ALK B) will publish its results for the first quarter of 2025 in the morning on Tuesday, 6 May 2025. Later on the same day, the company will host a presentation for investors and analysts at 11:00 a. [...]
FOXO TECHNOLOGIES INC. ANNOUNCES COMPLETION OF REVERSE STOCK SPLIT
29/04/2025
West Palm Beach, April 29, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “ Company ”), today announced that effective 4.01pm Eastern Time, on April 28, 2025, (the “Effective Time [...]
AscellaHealth Honored as Silver Stevie® Award Winner in 2025 American Business Awards®
29/04/2025
Stevie winners will be celebrated during gala event on June 10 in New York BERWYN, Pa., April 29, 2025 (GLOBE NEWSWIRE) -- AscellaHealth , a global partner delivering customizable solutions to support the specialty [...]
Axiom Medical Marks 25 Years of Advancing Workplace Safety and Health at Annual Client Summit
29/04/2025
Honors Exceptional Partners Driving Innovation in Employee Well-Being HOUSTON, TX, April 29, 2025 (GLOBE NEWSWIRE) -- Axiom Medical, a leader in occupational health and workplace injury case management solutions, [...]
Affimed Shows Higher Exposure of AFM24 is Associated with Significantly Higher Response Rates and Progression-Free Survival in Refractory NSCLC Patients at AACR Annual Meeting
29/04/2025
An exposure-outcome analysis in 72 patients with refractory non-small cell lung cancer (NSCLC) who received AFM24 at 480 mg weekly demonstrates that higher drug exposure (above median) leads to improved objective [...]
Kriya Announces Thirteen Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2025
29/04/2025
– Kriya’s platform includes fully integrated best-in-class manufacturing and research capabilities to support parallel advancement of a broad pipeline of gene therapies – – Current pipeline of gene therapies for chronic [...]
Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025
29/04/2025
Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignancies VANCOUVER, British Columbia, April 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. ( [...]

Pages